You searched for "treatment"
Rethinking tinnitus ‘care’: the role of digital solutions
Experiencing tinnitus can be very distressing and accessible care is limited. Digital therapeutics is one way of addressing these concerns, as described by Dr Bardy. Tinnitus presents a significant clinical challenge for various healthcare professionals, including general practitioners (GPs), ENTs...Reza Band<sup>®</sup> UES Assist Device
Members of the ENT and Audiology News team spoke to Rose Henrichs, Solutiones Vobis and Nick Maris, CEO and President of Somna Therapeutics about the Reza Band device. Nick Maris. Rose Henrichs. What is your involvement in Reza Band? And...
Medical trends in sleep disordered breathing
This duo provide an eloquent outline of sleep disordered breathing in general, with particular emphasis on the medical impact and associations of the condition. The increasing prevalence of the condition is described, with increasing worldwide obesity, increased association of cardiac...
Omalizumab for CRSwNP: a monoclonal antibody
A prospective study from London, evaluating the response of chronic rhinosinusitis patients with nasal polyposis who were being treated with monoclonal antibody against IgE for severe allergic asthma. Thirteen patients were treated with Omalizumab, according to UK guidelines for their...
Supplementing intranasal cortical steroids with montelukast: does it help?
Intranasal steroids are widely used in the treatment of allergic rhinitis. Whether or not the addition of montelukast helps was assessed in this study. This was a single centre prospective randomised double-blind placebo-controlled trial of two groups of patients, one...
The polyp shrinker
Inflammatory markers, including T2 cells beta common (βc) cytokines IL-3, IL5 and granulocyte-macrophage colony-stimulating factor (GM-CSF), are known to play an important role in chronic rhinosinusitis with nasal polyps (CRSwNP). CSL311, a monoclonal antibody (mAb), was developed to target human...
Extracapsular dissection alone for low-grade malignancies of the parotid gland – oncologically sound?
The general treatment strategy advocated for a primary carcinoma of the parotid gland is surgical resection +/- adjuvant radiotherapy. A selective neck dissection is usually recommended in all cases of parotid malignancies, except for small, low-grade tumours. In this paper,...
Coblation for lingual haemangiomas
Haemangiomas are benign vascular tumours characterised histologically by a marked proliferation of blood vessels. They can be either congenital or acquired, and can affect the tongue, both within the oral cavity and the oropharynx. A variety of interventions exist for...BSHENT Annual Meeting 2023
Katherine Conroy, MA (Cantab) MB BChir FRCS (ORL-HNS), Wythenshawe Hospital, Manchester, UK. The annual meeting of the British Society for the History of ENT was held at the Royal Society of Medicine’s historic Toynbee Mackenzie room. Dozens of attendees, from...1st Meeting on Olfactory Implants 2023
Liam Lee (left), Academic FY2 at Norfolk & Norwich University Hospital, Norwich, UK and Ms Tharsika Myuran (right), ENT ST7 Registrar, East of England. In the heart of Geneva, an exciting two-day symposium on olfactory implants took place for the...
Octreotide in the medical management of chyle fistula post neck dissection
Chyle leak, although rare (1% and 2.5%), is a well-documented complication following surgical dissection of the neck. Although the left side of the neck is the most common site, chyle fistulas have been reported in the right side of the...
